[11C]MK-6884

MK-6884 · Merck Sharp & Dohme LLC

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for [11C]MK-6884, covering 2019-02-28 to 2019-02-28. Get the full timeline:

Most recent: Clinical Trial Update: [11C]MK-6884 Positron Emission Tomography (PET) Tracer Validation Trial (MK-6884-001) [Phase 1]